<DOC>
	<DOC>NCT02550847</DOC>
	<brief_summary>The aim of this study was to evaluate MR/PET with both functional and molecular imaging on the prediction of prognosis in patients with suspected pancreatic cancer.</brief_summary>
	<brief_title>Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer</brief_title>
	<detailed_description>The results of MR/PET will be compared prospectively to dedicated MDCT or MR imaging, pathologic results, and clinical outcomes to assess the value of MR/PET in pancreatic cancers.</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>1. Diagnosed as pancreatic cancer 2. Between 20~90 years old 3. ECOG 02 4. Normal renal function 5. Measurable tumor size (&gt;1cm) 1. Contraindication for MRI exam 2. Claustrophobia 3. Renal insufficiency 4. Other malignancy 5. Pregnancy and lactating women</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>MR/PET</keyword>
	<keyword>pancreatic cancer</keyword>
</DOC>